This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries. Based on rich evidence, it draws policy recommendations to foster innovation in biopharmaceuticals advocating an integrated policy approach.
With case studies on Austria, Belgium (Flanders), Finland, Greece, Ireland, the Netherlands, Norway and Sweden, this book illustrates mechanisms and practices for better governance co-ordination and integration across policy areas.
This book presents case studies on innovation policy governance in Australia, Austria, Belgium (Flanders), Finland, Greece, Ireland, Japan, Korea, Netherlands, New Zealand, Norway and Sweden. It provides fresh insight into how governments are striving to make innovation policy more coherent.